Why the study?
Percutaneous debulking is a potential treatment option in patients with refractory mitral valve endocarditis who are not surgical candidates.
Answers are grounded in this paper and cite their sources.
Demonstrates the potential feasibility of percutaneous mechanical aspiration using the AngioVac system with cerebral protection for refractory mechanical mitral valve endocarditis in non-surgical candidates.
In patients with refractory mitral valve endocarditis who are not surgical candidates, percutaneous debulking is a potential treatment option. We describe the first report of percutaneous mechanical aspiration of prosthetic mechanical mitral valve endocarditis using the AngioVac system and cerebral protection devices.
No takes yet. Share an insight, caveat, or question.
Verghese et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: